These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9653)

  • 21. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines.
    Zubenko GS; Cohen BM
    Psychopharmacology (Berl); 1986; 88(2):230-6. PubMed ID: 2869541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenothiazine-induced dyskinesia in nursing-home patients.
    Greenblatt DL; Dominick JR; Stotsky BA; DiMascio A
    J Am Geriatr Soc; 1968 Jan; 16(1):27-34. PubMed ID: 4863733
    [No Abstract]   [Full Text] [Related]  

  • 24. Impairment of optokinetic nystagmus in patients with tardive dyskinesia.
    Lipper S
    Arch Gen Psychiatry; 1973 Mar; 28(3):331-3. PubMed ID: 4143946
    [No Abstract]   [Full Text] [Related]  

  • 25. Hazardous side effects of the phenothiazine drugs.
    Masłowski J
    Bull Inst Marit Trop Med Gdynia; 1987; 38(3-4):220-3. PubMed ID: 2906257
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug induced dyskinesia: reality or myth?
    Turek IS
    Dis Nerv Syst; 1975 Jul; 36(7):397-9. PubMed ID: 807464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Shy-Drager disease. Hemodynamic and pharmacodynamic studies. Value of cyproheptadine].
    Mahoudeau D; Singer B; Gilbert JC; Goulon M; Gajdos P
    Rev Neurol (Paris); 1972 Jun; 126(6):401-14. PubMed ID: 4667507
    [No Abstract]   [Full Text] [Related]  

  • 28. A middle ground in prophylactic antiparkinsonian medication.
    Huttenbach DE
    Am J Psychiatry; 1977 Jul; 134(7):820-1. PubMed ID: 17309
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate.
    Curran DJ; Nagaswami S; Mohan KJ
    Dis Nerv Syst; 1975 Feb; 36(2):71-3. PubMed ID: 1116418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and neurobiologic implications of antipsychotic-induced movement disorders.
    Rubin EH; Zorumski CF
    Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769
    [No Abstract]   [Full Text] [Related]  

  • 32. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyproheptadine and drug-induced anorgasmia.
    Jeffries JJ; Walker C
    Can J Psychiatry; 1987 Feb; 32(1):79. PubMed ID: 2880654
    [No Abstract]   [Full Text] [Related]  

  • 34. THE EFFECT OF SOME NEW ANTIHISTAMINES ON THE ANAPHYLACTIC MICROSHOCK OF THE GUINEA-PIG.
    HERXHEIMER H; STRESEMANN E
    Br J Pharmacol Chemother; 1963 Dec; 21(3):414-8. PubMed ID: 14110740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine induced tardive dyskinesia treated successfully with quetiapine: a case report.
    Ugurlu GK; Tufan E; Bilici R; Ugurlu M; Saglam S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):276-7. PubMed ID: 20868719
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.
    Mosnaim AD; Ranade VV; Wolf ME; Puente J; Antonieta Valenzuela M
    Am J Ther; 2006; 13(3):261-73. PubMed ID: 16772768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amantadine for dyskinesia tarda.
    Vale S; Espejel MA
    N Engl J Med; 1971 Mar; 284(12):673. PubMed ID: 5545614
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex differences in long-term adverse effects of phenothiazines.
    Lehmann HE; Ban TA
    Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763
    [No Abstract]   [Full Text] [Related]  

  • 40. Deanol in the treatment of tardive dyskinesia.
    Casey DE; Denny D
    Am J Psychiatry; 1975 Aug; 132(8):864-7. PubMed ID: 1147074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.